Aclarion Inc (ACON)
Aclarion Inc. is a healthcare technology company based in Broomfield, Colorado, and its common stock trades on NASDAQ under the ticker ACON. The company develops products that use magnetic resonance spectroscopy (MRS) and proprietary biomarkers to support clinical decision-making in spine care. Its NOCISCAN platform is designed to non-invasively assess the chemical composition of intervertebral discs, while the NOCISCAN MRS Exam Protocol is a custom software workflow for use with commercially available MRS pulse sequences during lumbar MRI procedures. Aclarion also provides imaging data transfer capabilities through AMBRA Healthcare. In addition, the NOCISCAN Post-Processor Suite includes NOCICALC, which processes raw exam data into spectra and biomarker calculations, and NOCIGRAM, which converts those results into NOCISCORES on a 0-10 scale.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-ACON
|
$3.42
|
35.7% Upside
|
Undervalued
|
$7.50
|
197.6% Upside
|
Bargain
|
Fair
|
0.0%
|
December 2, 2026
|
0.4x
|
86.7x
|
7.264 M
|
-9.032 M
|
0.0%
|
86.7%
|
10.3
|
88.2%
|
